Spatial phenotyping of human bronchial airways in obstructive lung disease
- PMID: 40604972
- PMCID: PMC12224523
- DOI: 10.1186/s12931-025-03315-5
Spatial phenotyping of human bronchial airways in obstructive lung disease
Abstract
Chronic respiratory diseases such as asthma and COPD involve interactions between multiple resident and immune cell types within bronchial airways, resulting in structural and functional changes. Thus cellular heterogeneity, arrangements and associated neighborhoods as well as interactions between cells and matrices represent intriguing yet challenging areas of study. Spatial phenotypic profiling facilitates exploration of these issues of the cellular microenvironment and identification of context-dependent cell-cell interactions. Utilizing spatial phenotyping, we interrogated the features and cellular landscape of lungs from non-asthmatics, asthmatics, and COPD in FFPE samples by developing a 10-plex antibody panel for the Akoya PhenoCycler®-Fusion system, focused on immune cells (CD45, CD3, CD4, CD8), proliferative cells (Ki67, PCNA), angiogenesis (CD34), epithelium (E-cadherin), smooth muscle (SMA) and extracellular matrix (collagen). We performed cell segmentation on multiplex immunofluorescence images and quantified marker intensity in each cell. Phenotypes were manually identified after normalization, integration, and clustering cells across samples. The composition, cell profiling, and distribution varied significantly between asthmatics and COPD compared to non-asthmatics emphasizing disease heterogeneity. Spatially agnostic analysis revealed that the matrix cluster was more abundant in COPD compared to non-asthmatics and asthmatics, consistent with a greater role for fibrosis. However, asthmatic patients had a higher proportion of unclassified and CD8 + clusters highlighting immune responses. Co-localization analysis showed near random distribution in non-asthmatics. But strong spatial interaction between T cells and other immune or matrix cells in asthma, and a higher avoidance of smooth muscle and immune cells, and of proliferative markers in both asthmatic and COPD. Niche analysis demonstrated different recurrent cell-cell interactions in asthmatic and COPD cohorts. In COPD, the matrix cell-enriched niche was more abundant, while in asthmatics, the unclassified cell-enriched niche was more prevalent compared to non-asthmatics. These findings provide insights into differential spatial organization of cells and tissues in asthma and COPD, with immune and epithelial mechanisms suggesting active inflammation and remodeling in asthma, but fibrotic processes in COPD, and potential role for vascular processes in both conditions.
Keywords: Airway epithelium; Asthma; CODEX; COPD; Cell-cell interactions; Cell-matrix interactions; Functional phenotyping; Immune cell; Mesenchyme; Neighborhoods; Spatial biology.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This research was conducted in accordance with the Declaration of Helsinki. All procedures were approved by the Mayo Clinic Research Ethics Committee. This is not a clinical study but involves patient lung tissue samples. Written informed consent for research use of tissue samples was obtained from patients during office visits by experienced research coordinators under Mayo IRB 16-009655. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Prakash YS, Halayko AJ, Gosens R, Panettieri RA Jr., Camoretti-Mercado B, Penn RB. Structure ATSAoR, and function. An official American thoracic society research statement: current challenges facing research and therapeutic advances in airway remodeling. Am J Respir Crit Care Med. 2017;195:e4–19. - DOI - PubMed
-
- Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2022;59. - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
